The interpretation of mpMRI is limited by expertise required and interobserver variability. Here we present an AI model, with ordinary accuracy level for diagnosing prostate cancer, the remarkable of false negative and sensitivity could help to reduce missed-diagnosis of PCa especially csPCa. To assess its performance in clinical setting, we curated internal and external validation, and performance of radiologists, AI model, human-machine synergy were compared, although AI performed suboptimal, the human-led synergy method performed equivalent to clinical assessment with improved consistency, which can serve as a comparison standard to more complex deep learning and synergy approaches in the future.
This abstract and the presentation materials are available to members only; a login is required.